In this paper, we propose a new approach to address the problem of designing pharmaceutical copayments. The rationale for positive copayments in our setting lies in the presence of budgetary constraints and, hence, in the need to raise funds in order to finance the costs of the treatments. We...

I consider changes in labor markets across U.S. states and counties around the enactment of the Affordable Care Act in 2010 and its implementation in 2014. I find that counties with large fractions of uninsured (and therefore a large exposure to the ACA) before the enactment or the...

When South Africa implemented its non-pharmaceutical interventions (NPIs) (its "lockdown") to stem the COVID-19 pandemic in March 2020, it was hailed as exemplary. By June 2020 however, the lockdown was in disarray: the number of confirmed infections continued to grow exponentially, placing the...

This paper presents preliminary summary results from a longitudinal study of participants in seven U.S. states during the COVID-19 pandemic. In addition to standard socio-economic characteristics, we collect data on various economic preference parameters: time, risk, and social preferences, and...

Due to high levels of obesity, various government interventions have been proposed to curb the consumption of sugar-sweetened beverages (SSBs). The New York City "soda-ban," which proposed to limit the size of SSBs is among the most well-known and controversial. While public debates about...

Background: Economic evaluation (EE) is a dynamically advancing knowledge area of health economics. It has been conceived to provide evidence for allocating scarce resources to gain the best value for money. The problem of efficiency of investments becomes even more crucial with advances in...

In this paper, we apply a Voronoi diagram to map the existing design of oncological care in Poland. First, we correlate the actual organization of care with epidemiological data on cancer survival rate and morbidity. On this basis, we build a proxy for localized demand for oncological care. As a...

Intermediaries may bargain with several upstream providers on behalf of consumers who do not directly pay for consumption, such as an insurer bargaining with hospitals. We show that the common Nash- in-Nash solution, while useful for estimation, can predict Nash overpricing: prices that exceed...

Many health economists demand more competition in the health care system. They focus on the competition between sickness funds for insured and the competition between health care providers for contracts with sickness funds. But they neglect the competition between health care providers for...